Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise MRD™, broadening availability to patients ...

Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate new approaches to increase germline genetic testing among at-risk family members Research will also assess the clinical ...

The diagnosis of Lynch syndrome in patients with colorectal cancer has evolved from reliance on clinical criteria to integrated molecular and genetic approaches. Genetic testing strategies typically ...

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients. Research from Radboud University Medical Center and University Hospital Bonn (UKB ...

So it's important to remember that all human beings have a risk of colorectal cancer. About 1 in 23 men will be diagnosed with colorectal cancer and about 1 in 25 women, but about 5 to 10% of those ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. March is Colon Cancer Awareness Month, an important time to ...

Colorectal cancer (CRC) is the second most common malignancy in the Republic of Kazakhstan, accounting for 10.6% of all cancer cases, after breast cancer (14.9%), lung cancer (10.5%), and stomach ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Learn who gets colon cancer, prevention tips, and the best way to catch it early.